ImmuCell Corporation
ICCC
$9.67
-$0.10-1.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.78% | 160.98% | 143.51% | 93.03% | 62.65% |
| Total Depreciation and Amortization | 1.58% | 0.33% | -0.76% | -1.15% | -1.10% |
| Total Amortization of Deferred Charges | 27.70% | 47.97% | 8.54% | 39.81% | 88.50% |
| Total Other Non-Cash Items | 1,356.33% | -107.86% | -70.65% | -58.70% | -59.55% |
| Change in Net Operating Assets | -405.07% | -768.97% | -404.25% | -47.85% | 80.75% |
| Cash from Operations | 591.59% | 649.46% | 1,198.40% | 201.30% | 107.66% |
| Capital Expenditure | -168.52% | -263.28% | -12.59% | 43.44% | 75.39% |
| Sale of Property, Plant, and Equipment | 702.22% | 591.11% | 323.19% | 80.00% | 80.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -163.29% | -437.72% | -9.39% | 43.68% | 75.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.30% | -55.75% | 55.87% | 54.88% | 53.91% |
| Issuance of Common Stock | -92.49% | -78.47% | 949.45% | 24,727.13% | 24,623.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 72.20% | 62.61% | 22.44% | -287.05% | -264.17% |
| Cash from Financing | -142.05% | -127.72% | 270.93% | 347.17% | 64.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.26% | -95.74% | 3,695.46% | 270.39% | 157.75% |